Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma

Journal of Neuroscience Research

Volumn 67, Issue 4, 2002, Pages 494-500

  Abramova, Nicole A ^a   Cassarino, David S ^a   Khan, Shaharyar M ^a   Painter, Terry W ^b   Bennett Jr , James P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b PFIZER INC   (United States)

Author keywords

Caspases; Cell death; Neurodegenerative diseases; Neuroprotection; Pramipexole

Indexed keywords

AMYLOID BETA PROTEIN; BONGKREKIC ACID; CALCEIN; CASPASE; CASPASE 3; CASPASE 9; CYTOCHROME C; METHYLPYRIDINIUM DERIVATIVE; PICOLINE DERIVATIVE; PRAMIPEXOLE; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROPROTECTION; NEUROTOXICITY; PARKINSON DISEASE; PRIORITY JOURNAL; STEREOISOMERISM;

1-METHYL-4-PHENYLPYRIDINIUM; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTI-BACTERIAL AGENTS; ARISTOLOCHIC ACIDS; BENZOTHIAZOLES; BONGKREKIC ACID; BRAIN; CASPASES; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HUMANS; NEUROBLASTOMA; NEURODEGENERATIVE DISEASES; NEURONS; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PHENANTHRENES; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0037083131     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10127     Document Type: Article

References (44)

1. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease
2. Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis
3. Neuroprotective effects of PPX in young and aged MPTP-treated mice
4. Oxidative metabolism
5. Energetics in the pathogenesis of neurodegenerative diseases
6. PPX - A new dopamine agonist for the treatment of Parkinson's disease
7. Mechanisms of action of PPX: Putative neuroprotective effects
8. An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
9. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
10. PPX reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion
11. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism
12. Interaction among mitochondria mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease
13. +
14. Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance
15. +-induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid
16. +-induced apoptosis in human SH-SY5Y neuroblastoma cells
17. The dopamine agonist PPX scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: An in vivo microdialysis study
18. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells
19. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
20. Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons
21. Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and PPX
22. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways
23. Protective effects of the antiparkinsonian drugs talipexole and PPX against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells
24. Antioxidant property of PPX independent of dopamine receptor activation in neuroprotection
25. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells
26. The efficacy of PPX in the treatment of Parkinson's disease
27. The role of mitochondria in the pathogenesis of neurodegenerative diseases
28. Beta-amyloid-induced activation of caspase-3 in primary cultures of rat neurons
29. N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: Effects on beta-amyloid secretion and tau phosphorylation
30. PPX vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial
31. Neurotoxic Aβ Peptides increase oxidative stress in vivo through NMDA receptor and nitric oxide synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro
32. Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effect
33. Dopamine autoreceptor agonists: Resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole an aminothiazole analogue of apomorphine
34. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease
35. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease
36. +-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase
37. Origin and functional consequences of the complex I defect in Parkinson's disease
38. Cybrids in Alzheimer's disease: A cellular model of the disease?
39. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family
40. Mitochondria in sporadic amyotrophic lateral sclerosis
41. Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and PPX
42. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic Bcl-2 and Bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress
43. Maternal inheritance in Parkinson's disease
44. PPX inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice